Results 41 to 50 of about 311,459 (229)

Biomarkers for neuromyelitis optica: a visual analysis of emerging research trends

Neural Regeneration Research
Neuromyelitis optica is an inflammatory demyelinating disease of the central nervous system that differs from multiple sclerosis. Over the past 20 years, the search for biomarkers for neuromyelitis optica has been ongoing.
Xiangjun Li, Jiandong Zhang, Siqi Zhang, Shengling Shi, Yi’an Lu, Ying Leng, Chunyan Li   +6 more
doaj   +1 more source

The efficacy of rituximab in the therapy of neuromyelitis optica in a patient with Sjogren's syndrome: case-report and literature review [PDF]

Терапевтический архив, 2018
This case is the first description of the successful anti-B-cell therapy with rituximab in a patient with Sjogrenʼs syndrome and neuromyelitis optica spectrum disorder in Russia.
A V Torgashina, V I Vasilyev
doaj   +1 more source

Neuromyelitis optica spectrum disorder with increased aquaporin-4 microparticles prior to autoantibodies in cerebrospinal fluid: a case report

Journal of Medical Case Reports, 2019
Background Neuromyelitis optica spectrum disorders are severe autoimmune inflammatory diseases of the central nervous system associated with the presence of immunoglobulin G antibodies against the water channel protein aquaporin-4.
Susanne Bejerot, Eva Hesselmark, Fariborz Mobarrez, Håkan Wallén, Max Albert Hietala, Rolf Nybom, Lennart Wetterberg   +6 more
doaj   +1 more source

Electrical muscle stimulation intervention in the acute phase of neuromyelitis optica: Two case reports

SAGE Open Medical Case Reports, 2020
The aim of this study was to examine the effect of electrical muscle stimulation on muscle atrophy caused by neuromyelitis optica. Two neuromyelitis optica patients with flaccid paralysis participated.
Kana Michiue, Yuichi Nishikawa
doaj   +1 more source

The Treatment of Neuromyelitis Optica [PDF]

Journal of Neuro-Ophthalmology, 2014
Neuromyelitis optica (NMO) is an autoimmune disorder of the central nervous system directed against astrocytes. Initially diagnosed in individuals with monophasic or relapsing optic neuritis and transverse myelitis, NMO is now recognized as a demyelinating disorder with pleiotropic presentations due to the identification of a specific autoantibody ...
Markus C, Kowarik, John, Soltys, Jeffrey L, Bennett   +2 more
openaire   +2 more sources

Aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorders: progress of experimental models based on disease pathogenesis

Neural Regeneration Research
Neuromyelitis optica spectrum disorders are neuroinflammatory demyelinating disorders that lead to permanent visual loss and motor dysfunction. To date, no effective treatment exists as the exact causative mechanism remains unknown.
Li Xu, Huiming Xu, Changyong Tang
doaj   +1 more source

Neuromyelitis optica spectrum disorder with AQP4‐IgG presenting as area postrema syndrome and progressing to myelitis: A rare case report

Clinical Case Reports, 2023
Key Clinical Message Neuromyelitis optica spectrum disorders can less commonly present with area postrema syndrome progressing to myelitis. Management involves intravenous glucocorticoids, plasma exchange, and preventive immunotherapy.
Preethi Jagannath, Mohammed Suhail K, Shaikh Mohammed Aslam S, Ashwin Kulkarni, Polasu Sri Satya Sai Prashanth, Hritik Madan, Ayush Anand   +6 more
doaj   +1 more source

Establishing an Apheresis Medicine Program in a Resource‐Constrained Setting: A 5‐Year Experience From Lagos, Nigeria

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Establishing a comprehensive apheresis medicine program in a resource‐constrained setting presents significant structural, financial, and logistical challenges. Despite the growing clinical importance of apheresis services globally, published experience from sub‐Saharan Africa remains sparse.
Folasade Adelekan‐Popoola, Shakirat Gold‐Olufadi, Olufunto Olufela Kalejaiye, Abdullateef Ogala, Rasheed A. Balogun   +4 more
wiley   +1 more source

Immunotherapy of Neuromyelitis Optica [PDF]

Autoimmune Diseases, 2013
Neuromyelitis optica (NMO) is a chronic inflammatory disease of the central nervous system that affects the optic nerves and spinal cord resulting in visual impairment and myelopathy. There is a growing body of evidence that immunotherapeutic agents targeting T and B cell functions, as well as active elimination of proinflammatory molecules from the ...
Benjamin Bienia, Roumen Balabanov
openaire   +2 more sources

N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes [PDF]

, 2010
Antibodies to the N-methyl-d-aspartate subtype of glutamate receptor have been associated with a newly-described encephalopathy that has been mainly identified in young females with ovarian tumours.
Irani, Sarosh R., Zandi, Michael S, Friese, MA, Kullmann, DM, Zuliani, Luigi, Bien, Christian G., Waters, Patrick, Irani, SR, Friese, Manuel A, Galea, Ian, Kullmann, Dimitri M., Maxwell, S, Lang, Bethan, Lang, B, Zuliani, L, Bien, CG, Bera, K, Maxwell, Susan, Zandi, MS, Vincent, Angela, Beeson, David, Vincent, A, Friese, Manuel A., Galea, I, Bera, Katarzyna, Zandi, Michael S., Waters, P, Beeson, D   +27 more
core   +1 more source